Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
GB2140684A - Mineral oil composition for use in the treatment of eczema - Google Patents
[go: Go Back, main page]

GB2140684A - Mineral oil composition for use in the treatment of eczema - Google Patents

Mineral oil composition for use in the treatment of eczema Download PDF

Info

Publication number
GB2140684A
GB2140684A GB08311206A GB8311206A GB2140684A GB 2140684 A GB2140684 A GB 2140684A GB 08311206 A GB08311206 A GB 08311206A GB 8311206 A GB8311206 A GB 8311206A GB 2140684 A GB2140684 A GB 2140684A
Authority
GB
United Kingdom
Prior art keywords
composition
paint
eczema
treatment
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08311206A
Other versions
GB8311206D0 (en
GB2140684B (en
Inventor
Stavros Christodoulou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB08311206A priority Critical patent/GB2140684B/en
Publication of GB8311206D0 publication Critical patent/GB8311206D0/en
Publication of GB2140684A publication Critical patent/GB2140684A/en
Application granted granted Critical
Publication of GB2140684B publication Critical patent/GB2140684B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A61K35/06Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/242Gold; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Paints Or Removers (AREA)
  • Medicinal Preparation (AREA)

Abstract

A topical composition for the treatment of eczema comprises a mixture of a major part of mineral oil containing suspended carbon particles and a minor part of a paint containing a finely divided metallic pigment. The oil component with suspended carbon is preferably used engine oil from the sump of an internal combustion engine The metallic paint may be a silver, copper or gold coloured paint wherein the pigment is one or more of powdered zinc, copper, tin, antimony or preferably aluminium.

Description

SPECIFICATION Composition for use in the treatment of eczema This invention relates to a composition for use in the treatment of eczema.
Eczema is a name given to a variety of skin infections, the effect of which is to cause reddening and scaling of the skin giving rise to considerable discomfort through itching. Hitherto, the majority of treatments for eczema have not served so much to remove the source of infection but merely to suppress the itching effect so that the skin will be able to heal of its own accord.
Frequently such compositions are not effective and scratching of the skin continues to such an extent that healing never has much opportunity to take place.
It is an object of the present invention to provide a composition which when applied to an area of skin affected by eczema not only suppresses itching taking place but is efficacious in suppressing the eczema itself.
According to the present invention there is provided a composition for use in the treatment of eczema which is a mixture of a major part of mineral oil containing in suspension carbon particles and a minor part of a paint composition containing a metallic pigment therein.
The composition of this invention comprises two essential components both of which are readily available at relatively low cost. The mineral oil component containing suspended carbon may be simply spent engine oil from the sump of an internal combustion engine. Although such a composition is certainly dirty and totally unsuitable for internal consumption, when applied externally, no harmful effects have been observed.
There is therefore no need to employ fresh oil with suspended carbon therein and indeed, although it has not been possible to prove, it could well be that the inorganic and organic compounds found in spent engine oil are beneficial in the treatment of eczema.
The paint component of the composition of this invention is likewise harmless if applied to the skin. There are commonly employed in paints three types of metallic pigment to produce a socalled "metallic" paint. These are aluminium which is commonly employed in silver paint, bronze pigment containing the elements copper, tin, antimony and zinc which is commonly employed in gold paints and zinc pigment employed primarily in primer paints. The so-called silver paints containing aluminium pigment are preferably employed in the practice of this invention.
In producing the compositions of this invention, the paint is merely mixed with the spent engine oil. The ratio by volume between these components may be varied widely. In general the oil and paint will be employed in a ratio by volume offrom 10:1 to 30:1, preferably 1 5:1 to 25:1 and most preferably about 20:1. Thus a composition which has been found to the particularly effective has been produced by mixing 1 oz. (28.4 g) of commercially available silver paint with 1 pint (0.57 litre) of spent engine oil.
Treatment with the composition of this invention is effected by painting the composition on the affected area of skin by any convenient method. The skin is preferably left fully exposed to the air for as long as possible while the composition is in contact therewith. When the composition has dried, it may generally be removed by peeling. In usual cases, it will suffice for the composition to be applied daily for about one month. Generally treatment for more than two months will not be necessary.
The composition of this invention has been tested on about 200 subjects suffering from eczema. The treatment with the composition has been found to be successful in all cases.
1. A composition for use in the treatment of eczema which is a mixture of a major part of a mineral oil containing in suspension carbon particles and a minor part of a paint composition containing a metallic pigment therein.
2. A composition as claimed in claim 1, wherein the mineral oil containing in suspension carbon particles is spent engine oil from the sump of an internal combustion engine.
3. A composition as claimed in claim 1 or 2, wherein the paint composition is a silver paint containing aluminium pigment.
4. A composition as claimed in any one of the preceding claims, wherein the oil and paint are present in a ratio by volume of from 10:1 to 30:1.
5. A composition as claimed in claim 4, wherein the oil and paint are employed in a ratio by volume offrom 15:1 to 25:1.
6. A composition for use in the treatment of eczema, substantially as described herein.
**WARNING** end of DESC field may overlap start of CLMS **.

Claims (6)

**WARNING** start of CLMS field may overlap end of DESC **. SPECIFICATION Composition for use in the treatment of eczema This invention relates to a composition for use in the treatment of eczema. Eczema is a name given to a variety of skin infections, the effect of which is to cause reddening and scaling of the skin giving rise to considerable discomfort through itching. Hitherto, the majority of treatments for eczema have not served so much to remove the source of infection but merely to suppress the itching effect so that the skin will be able to heal of its own accord. Frequently such compositions are not effective and scratching of the skin continues to such an extent that healing never has much opportunity to take place. It is an object of the present invention to provide a composition which when applied to an area of skin affected by eczema not only suppresses itching taking place but is efficacious in suppressing the eczema itself. According to the present invention there is provided a composition for use in the treatment of eczema which is a mixture of a major part of mineral oil containing in suspension carbon particles and a minor part of a paint composition containing a metallic pigment therein. The composition of this invention comprises two essential components both of which are readily available at relatively low cost. The mineral oil component containing suspended carbon may be simply spent engine oil from the sump of an internal combustion engine. Although such a composition is certainly dirty and totally unsuitable for internal consumption, when applied externally, no harmful effects have been observed. There is therefore no need to employ fresh oil with suspended carbon therein and indeed, although it has not been possible to prove, it could well be that the inorganic and organic compounds found in spent engine oil are beneficial in the treatment of eczema. The paint component of the composition of this invention is likewise harmless if applied to the skin. There are commonly employed in paints three types of metallic pigment to produce a socalled "metallic" paint. These are aluminium which is commonly employed in silver paint, bronze pigment containing the elements copper, tin, antimony and zinc which is commonly employed in gold paints and zinc pigment employed primarily in primer paints. The so-called silver paints containing aluminium pigment are preferably employed in the practice of this invention. In producing the compositions of this invention, the paint is merely mixed with the spent engine oil. The ratio by volume between these components may be varied widely. In general the oil and paint will be employed in a ratio by volume offrom 10:1 to 30:1, preferably 1 5:1 to 25:1 and most preferably about 20:1. Thus a composition which has been found to the particularly effective has been produced by mixing 1 oz. (28.4 g) of commercially available silver paint with 1 pint (0.57 litre) of spent engine oil. Treatment with the composition of this invention is effected by painting the composition on the affected area of skin by any convenient method. The skin is preferably left fully exposed to the air for as long as possible while the composition is in contact therewith. When the composition has dried, it may generally be removed by peeling. In usual cases, it will suffice for the composition to be applied daily for about one month. Generally treatment for more than two months will not be necessary. The composition of this invention has been tested on about 200 subjects suffering from eczema. The treatment with the composition has been found to be successful in all cases. CLAIMS
1. A composition for use in the treatment of eczema which is a mixture of a major part of a mineral oil containing in suspension carbon particles and a minor part of a paint composition containing a metallic pigment therein.
2. A composition as claimed in claim 1, wherein the mineral oil containing in suspension carbon particles is spent engine oil from the sump of an internal combustion engine.
3. A composition as claimed in claim 1 or 2, wherein the paint composition is a silver paint containing aluminium pigment.
4. A composition as claimed in any one of the preceding claims, wherein the oil and paint are present in a ratio by volume of from 10:1 to 30:1.
5. A composition as claimed in claim 4, wherein the oil and paint are employed in a ratio by volume offrom 15:1 to 25:1.
6. A composition for use in the treatment of eczema, substantially as described herein.
GB08311206A 1983-04-25 1983-04-25 Mineral oil composition for use in the treatment of eczema Expired GB2140684B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08311206A GB2140684B (en) 1983-04-25 1983-04-25 Mineral oil composition for use in the treatment of eczema

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08311206A GB2140684B (en) 1983-04-25 1983-04-25 Mineral oil composition for use in the treatment of eczema

Publications (3)

Publication Number Publication Date
GB8311206D0 GB8311206D0 (en) 1983-06-02
GB2140684A true GB2140684A (en) 1984-12-05
GB2140684B GB2140684B (en) 1986-07-30

Family

ID=10541648

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08311206A Expired GB2140684B (en) 1983-04-25 1983-04-25 Mineral oil composition for use in the treatment of eczema

Country Status (1)

Country Link
GB (1) GB2140684B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
US6989156B2 (en) 2001-04-23 2006-01-24 Nucryst Pharmaceuticals Corp. Therapeutic treatments using the direct application of antimicrobial metal compositions
US7201925B2 (en) 2002-04-23 2007-04-10 Nueryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases
WO2008151640A3 (en) * 2007-06-09 2009-02-05 Mustapha Lefkir Product for combating the reappearance of hair
US8865227B2 (en) 2007-12-20 2014-10-21 Smith & Nephew (Overseas) Limited Metal carbonate particles and methods of making thereof

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7137968B1 (en) 2000-03-13 2006-11-21 Nucryst Pharmaceuticals Corp. Transcutaneous medical device dressings and method of use
AU2001278322B2 (en) 2000-07-27 2005-12-22 Smith & Nephew (Overseas) Limited Treatment of hyperproliferative skin disorders and diseases
US7008647B2 (en) 2001-04-23 2006-03-07 Nucryst Pharmaceuticals Corp. Treatment of acne
US7255881B2 (en) 2000-07-27 2007-08-14 Nucryst Pharmaceuticals Corp. Metal-containing materials
US20030185901A1 (en) 2000-07-27 2003-10-02 Burrell Robert E. Methods of treating conditions with a metal-containing material
US7001617B2 (en) 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US6989157B2 (en) 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
US20030180379A1 (en) 2000-07-27 2003-09-25 Burrell Robert E. Solutions and aerosols of metal-containing compounds
US7427416B2 (en) 2000-07-27 2008-09-23 Nucryst Pharmaceuticals Corp. Methods of treating conditions using metal-containing materials

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
US6989156B2 (en) 2001-04-23 2006-01-24 Nucryst Pharmaceuticals Corp. Therapeutic treatments using the direct application of antimicrobial metal compositions
US7201925B2 (en) 2002-04-23 2007-04-10 Nueryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases
WO2008151640A3 (en) * 2007-06-09 2009-02-05 Mustapha Lefkir Product for combating the reappearance of hair
US8865227B2 (en) 2007-12-20 2014-10-21 Smith & Nephew (Overseas) Limited Metal carbonate particles and methods of making thereof

Also Published As

Publication number Publication date
GB8311206D0 (en) 1983-06-02
GB2140684B (en) 1986-07-30

Similar Documents

Publication Publication Date Title
GB2140684A (en) Mineral oil composition for use in the treatment of eczema
CA2208078A1 (en) Formulations and methods for reducing skin irritation
CA2151884A1 (en) Diecasting alloy
AU697817B2 (en) Sorbent compositions for sulfur removal
CA2108192A1 (en) Use of tyloxapol as a nanoparticle stabilizer and dispersant
ZA837976B (en) Imidazolylalkylthienyl-tetrahydropyridazines and processes for their preparation
AU560726B2 (en) Triazolo(3,4-a)phthalazine and their use as anti-anxiety agents
BR8206165A (en) 1,2-ALCANODIOL BORATED COMPOUND, LUBRICATING OIL COMPOSITION AND PROCESS TO REDUCE THE OIL CONSUMPTION OF AN INTERNAL COMBUSTION ENGINE
ATE170979T1 (en) PREPARATION AND STABILIZATION OF CELL SUSPENSIONS
GR3031321T3 (en) Isothiourea derivatives as no synthase inhibitors
ES2051760T3 (en) NEW CERIO IV COMPOUND AND ITS PREPARATION PROCEDURE.
KR880002608A (en) Submerged Ike Welding Flux
IL105489A0 (en) Compositions and methods for improving the wetting of particulates
ATE185071T1 (en) STEROID-CONTAINING EYE COMPOSITIONS AND THEIR USE IN THE TREATMENT OF GLAUCOMA
CA2010606A1 (en) Lubricating oil compositions and additives for use therein
IE792418L (en) Diazines.
AU1543283A (en) Biostimulating agent containing creatine
ES8501397A1 (en) Amino derivatives of benzylidene-pyrrolo[2,1-b]quinazolines useful for treating conditions of allergic origin
RU96111994A (en) COMPOSITION FOR PROTECTION AGAINST CORROSION AND THERMAL-OXIDATIVE TURNING OF CONNECTED SURFACES
JPS57207651A (en) Treatment of inorganic pigment
EP0264530A2 (en) Solvent for paint
RU96124223A (en) COOLING LIQUID FOR INTERNAL COMBUSTION ENGINES
GB959509A (en) Improvements relating to nickel-chromium alloys
SU852910A1 (en) Composition "klemma-2" for ultrasound treatment of metals
RU93003065A (en) CHARGE FOR BEAST-FREE DECOMPOSITION OF METAL-CONTAINING MATERIALS

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19950425